Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
1997 1
1998 2
1999 3
2002 1
2004 3
2005 2
2006 10
2007 13
2008 6
2009 13
2010 8
2011 7
2012 9
2013 11
2014 19
2015 23
2016 14
2017 11
2018 18
2019 32
2020 26
2021 41
2022 26
2023 29
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
VEGFR1 signaling in retinal angiogenesis and microinflammation.
Uemura A, Fruttiger M, D'Amore PA, De Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. Uemura A, et al. Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25. Prog Retin Eye Res. 2021. PMID: 33640465 Free PMC article. Review.
Although much research has been conducted on VEGFR2 to elucidate its key role in retinal diseases, recent efforts have shown the importance and involvement of VEGFR1 and its family of ligands in angiogenesis, vascular permeability, and microinflammatory cascades within the …
Although much research has been conducted on VEGFR2 to elucidate its key role in retinal diseases, recent efforts have shown the impo …
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.
Vitale A, Cabibbo G, Iavarone M, Viganò L, Pinato DJ, Ponziani FR, Lai Q, Casadei-Gardini A, Celsa C, Galati G, Gambato M, Crocetti L, Renzulli M, Giannini EG, Farinati F, Trevisani F, Cillo U; HCC Special Interest Group of the Italian Association for the Study of the Liver. Vitale A, et al. Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9. Lancet Oncol. 2023. PMID: 37414020 Review.
In this Policy Review we critically appraise how treatment allocation strictly based on pretreatment staging features has shifted towards a more personalised treatment approach, in which expert tumour boards assume a central role. We propose an evidence-based framework for …
In this Policy Review we critically appraise how treatment allocation strictly based on pretreatment staging features has shifted towards a …
Alkali-labile gangliosides.
Mauri L, Sonnino S. Mauri L, et al. Glycoconj J. 2023 Jun;40(3):269-276. doi: 10.1007/s10719-023-10103-0. Epub 2023 Jan 25. Glycoconj J. 2023. PMID: 36695939 Free PMC article. Review.
Starting from biochemical data we will discuss the possible biochemical role played by these gangliosides in the processes of cell signaling and maintenance of brain functions....
Starting from biochemical data we will discuss the possible biochemical role played by these gangliosides in the processes of cell si …
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.
Barchiesi G, Mazzotta M, Krasniqi E, Pizzuti L, Marinelli D, Capomolla E, Sergi D, Amodio A, Natoli C, Gamucci T, Vizza E, Marchetti P, Botti C, Sanguineti G, Ciliberto G, Barba M, Vici P. Barchiesi G, et al. Int J Mol Sci. 2020 May 16;21(10):3528. doi: 10.3390/ijms21103528. Int J Mol Sci. 2020. PMID: 32429381 Free PMC article. Review.
In locally advanced (LA) breast cancer (BC), neoadjuvant treatments have led to major achievements, which hold particular relevance in HER2-positive and triple-negative BC. Conversely, their role in hormone receptor positive (HR+), hormone epidermal growth factor 2 negativ …
In locally advanced (LA) breast cancer (BC), neoadjuvant treatments have led to major achievements, which hold particular relevance in HER2- …
Glycosphingolipids.
Chiricozzi E, Aureli M, Mauri L, Di Biase E, Lunghi G, Fazzari M, Valsecchi M, Carsana EV, Loberto N, Prinetti A, Sonnino S. Chiricozzi E, et al. Adv Exp Med Biol. 2021;1325:61-102. doi: 10.1007/978-3-030-70115-4_3. Adv Exp Med Biol. 2021. PMID: 34495530
Glycosphingolipids are amphiphilic plasma membrane components formed by a glycan linked to a specific lipid moiety. In this chapter we report on these compounds, on their role played in our cells to maintain the correct cell biology.In detail, we report on their structure, …
Glycosphingolipids are amphiphilic plasma membrane components formed by a glycan linked to a specific lipid moiety. In this chapter we repor …
An open chat with Sandro Sonnino.
Tsagakis I, Sonnino S. Tsagakis I, et al. FEBS Open Bio. 2023 Sep;13(9):1544-1547. doi: 10.1002/2211-5463.13689. Epub 2023 Aug 22. FEBS Open Bio. 2023. PMID: 37589211 Free PMC article.
Sandro Sonnino is one of the founding members of the Editorial Board of FEBS Open Bio, having joined in 2011. ...In this interview, Sandro Sonnino discusses the ongoing importance of research on glycosphingolipids and his personal career journey....
Sandro Sonnino is one of the founding members of the Editorial Board of FEBS Open Bio, having joined in 2011. ...In this interview, …
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Harter P, Mouret-Reynier MA, Pignata S, Cropet C, González-Martín A, Bogner G, Fujiwara K, Vergote I, Colombo N, Nøttrup TJ, Floquet A, El-Balat A, Scambia G, Guerra Alia EM, Fabbro M, Schmalfeldt B, Hardy-Bessard AC, Runnebaum I, Pujade-Lauraine E, Ray-Coquard I. Harter P, et al. Gynecol Oncol. 2022 Feb;164(2):254-264. doi: 10.1016/j.ygyno.2021.12.016. Epub 2021 Dec 22. Gynecol Oncol. 2022. PMID: 34952708 Free article. Clinical Trial.
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín Lorente C, Berton D, Runnebaum IB, Ray-Coquard I. Pujade-Lauraine E, et al. JCO Precis Oncol. 2023 Jan;7:e2200258. doi: 10.1200/PO.22.00258. JCO Precis Oncol. 2023. PMID: 36716415 Free PMC article. Clinical Trial.
315 results